Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-04-04 (benzinga.com)
Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks - Alnylam Pharmaceuticals (NASDAQ:ALNY), Amgen (NASDAQ:AMGN) -
Trump's new tariff move may raise U.S. pharma costs, with analysts warning of risks tied to EU manufacturing and shifting healthcare policies.
Read more
2024-02-20 (cnbc.com)
Healthy Returns: Alzheimer’s drug Leqembi launch, Apple Vision Pro nausea
The Alzheimer's drug Leqembi from Biogen and Eisai is seeing a slow launch, but demand is rising. Meanwhile, headsets are making some users nauseous.
Read more
2023-09-04 (e-fundresearch.com)
Nomura Fds Asia ex Japan High Cnv F GBP | IE00BMWHQC61 | e-fundresearch.com
Deep sea mining is important due to the increasing global demand for mineral raw materials
Read more
2020-11-08 (rttnews.com)
Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing
During the week ended November 6, two healthcare stocks generated triple-digit gains - Aptevo Therapeutics Inc. (APVO) was up over 266% and Oncternal Therapeutics Inc.
Read more
2020-06-10 (bioprocessintl.com)
Fujifilm invests $928m to double capacity at ex-Biogen plant, adding 300 jobs
Fujifilm will increase bioreactor capacity to 240,000 L at the recently acquired site in Denmark, feeding the high demand for biomanufacturing services.
Read more